Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cabergoline and Hydroxyethyl Starch in Ovarian Hyperstimulation Syndrome Prevention

This study has been completed.
Information provided by (Responsible Party):
Roberto Matorras, Hospital de Cruces Identifier:
First received: January 26, 2012
Last updated: February 9, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):